What does a positive Epstein-Barr virus (EBV) IgG and negative IgM indicate in a patient who experienced fever, sore throat, and fatigue 1.5 months ago?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EBV IgG Positive with Negative IgM: Past Infection

Your patient's positive EBV IgG with negative IgM indicates a past EBV infection, not an acute infection. The symptoms experienced 1.5 months ago were likely the acute infectious mononucleosis episode, and the current serological pattern confirms you are now seeing the convalescent phase 1, 2.

Interpretation of This Serological Pattern

The combination of positive VCA IgG and negative VCA IgM represents the classic serological signature of past EBV infection 1. Here's what happened in your patient's timeline:

  • 1.5 months ago: Acute infection with fever, sore throat, and fatigue (classic infectious mononucleosis symptoms) 3, 4
  • Now: IgM antibodies have waned below detectable levels, while IgG antibodies persist, indicating resolved primary infection

Critical Next Step: Check EBNA-1 IgG

You need to order EBNA-1 IgG to complete the serological picture 1, 2:

  • If EBNA-1 IgG is positive: Confirms past infection (typically appears 3-4 weeks after symptom onset and persists for life) 5
  • If EBNA-1 IgG is negative: This would be unusual at 1.5 months post-symptoms and might suggest:
    • Delayed EBNA-1 response (can occur in some patients)
    • Immunocompromised state causing secondary anti-EBNA-1-negative pattern 5

Why This Matters Clinically

The distinction between acute and past infection has important implications:

This patient does NOT have:

  • Active acute EBV infection requiring monitoring
  • Chronic active EBV infection (CAEBV), which requires persistent or recurrent IM-like symptoms with elevated VCA-IgG titers (≥1:640) and elevated EA-IgG (≥1:160) 6

This patient HAS:

  • Resolved primary EBV infection
  • Lifelong EBV latency (normal state for 90% of adults) 3
  • No need for antiviral therapy or specific treatment

Common Pitfall to Avoid

Do not misinterpret isolated VCA IgG as acute infection. Studies show that 42.9% of atypical EBV profiles consist of isolated VCA IgG, which is 100% specific for past infection 7. The absence of VCA IgM is the key differentiator—VCA IgM typically disappears within 4-12 weeks after acute infection 1, 2.

If Symptoms Persist or Recur

Should your patient develop new or persistent symptoms beyond the expected recovery period (infectious mononucleosis typically lasts several weeks 3, 4), you would need to:

  1. Rule out other causes of their symptoms (not ongoing EBV)
  2. Consider CAEBV only if: Persistent/recurrent IM-like symptoms + markedly elevated VCA-IgG (≥1:640) + elevated EA-IgG (≥1:160) 6
  3. Obtain EBV PCR (viral load in peripheral blood) if CAEBV is suspected 6

The current serological pattern with symptoms 1.5 months ago represents straightforward resolved primary EBV infection requiring no further EBV-specific workup or treatment.

References

Research

Primary Epstein-Barr virus infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2018

Research

Infectious Mononucleosis.

Current topics in microbiology and immunology, 2015

Related Questions

Do the EBV serology results showing very high viral capsid antigen IgG, very high nuclear antigen IgG, positive heterophile antibody, and negative EBV DNA PCR indicate a prior infection rather than active disease, and what management is recommended?
How many weeks after Epstein-Barr Virus (EBV) infection would Immunoglobulin G (IgG) to Viral Capsid Antigen (VCA) be detectable?
What does the presence of Epstein-Barr Virus (EBV) Immunoglobulin M (IgM) antibodies in a patient's blood indicate, and how should the patient be managed?
What does a rising Epstein‑Barr virus IgG level with IgM below the laboratory cutoff (<10 U/mL) indicate about infection status and recommended management?
What is the significance of Epstein‑Barr virus (EBV) serology results showing viral capsid antigen IgG 103 U, viral capsid antigen IgM 26.4 U, and EBV nuclear antigen IgG 92.1 U?
For a patient with mild hypotension who is stable on the ward, over what time period should 1 L of lactated Ringer’s solution be infused?
How should I treat a patient with a negative rapid streptococcal test but a positive throat culture for group A Streptococcus?
What is the appropriate N‑acetylcysteine (NAC) dose in milliliters (cc) for a patient with acetaminophen (paracetamol) overdose?
How long does group A Streptococcus (strep throat) remain contagious?
What is the appropriate unfractionated heparin (UFH) infusion dosing for this patient?
What is the appropriate cefprozil dosage for streptococcal pharyngitis in adults and children, and when should it be used instead of penicillin or amoxicillin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.